Low-Carb/Time-restricted Feeding Protocol in Insulin-Using Type 2 Diabetics

Type2 Diabetes Clinical Trial

Official title:

Feasibility Study of a Low-Carb/Time-restricted Feeding Protocol in Insulin-Using Type 2 Diabetics

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04558827
• Other study ID #: 2020-0140
• Secondary ID: A534253SMPH/MEDI
• Status: Completed
• Phase: N/A
• Start date: February 1, 2021
• Est. completion date: January 24, 2022

Study information

• Verified date: March 2022
• Source: University of Wisconsin, Madison
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The current paradigm of Type 2 Diabetes treatment relies heavily on expensive pharmacotherapy even though lifestyle factors are at the root of the condition. This study is designed to assess the feasibility of a low carbohydrate diet coupled with a time restricted feeding intervention to improve participant sensitivity, reducing their need for insulin. 20 participants will be invited to enroll from the 20 S Park St Clinic in Madison, WI and remain on study for up to 6 months.

Description:

The investigators will perform a prospective cohort study of 20 insulin-using Type 2 diabetics who have primary care providers at 20 S Park St Clinic. Participants will be recruited from the Internal Medicine practices at the clinic. The subjects will meet with Dr. Zimmermann (Study Clinician) to review time restricted feeding and low-carbohydrate diets as well as a strategy for decreasing insulin doses. Calls from Dr. Zimmermann's clinic nurse will occur daily until blood glucose levels stabilize to manage insulin decrease.

Participants will complete monthly logs of food intake times and meet with a dietician twice during the 6-month study. Diabetes medication use will be reviewed, and hemoglobin A1c will be measured, at baseline and at 3 and 6 months. The participants' non-diabetic medical care will continue to be managed through their primary care physicians (PCPs).

Specific Aims:

• Demonstrate feasibility of the low carbohydrate/time restricted feeding (LC/TRF) protocol

• Feasibility will be assessed based on participant compliance with time-restricted feeding and recommended carbohydrate intake, clinician time and clinic resources

• Determine effectiveness of the LC/TRF protocol on diabetes care and quality of life

• Effectiveness on diabetes care will be evaluated using changes in A1c, insulin use, BMI, patient quality of life, and adverse events including hypoglycemia.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: January 24, 2022
• Est. primary completion date: January 24, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patient of a primary care provider at 20 S Park Internal Medicine Clinic

• Insulin using type 2 diabetic

• Using glargine or detemir insulin for basal insulin dosing

• Self-administering insulin

• Hemoglobin A1c 7-10%.

• Stable diabetes regimen for >3 months

• Demonstrated reliability with glucose monitoring, A1c checks

• BMI 25-35

Exclusion Criteria:

• History consistent with type 1 diabetes

• Using concentrated insulin (U200 or U300)

• Living in a skilled nursing facility

• Unwilling or unable to do frequent (3x daily) blood glucose checks

• eGFR (estimated glomerular filtration rate) < 30 mL/min per 1.73 m2

• Currently on steroids or warfarin

• Hospitalized within 3 months

• Symptomatic heart failure

• Weight Loss >10% in last six months

• History of organ transplantation

• Pregnant/trying to become pregnant/breast feeding

Related Conditions & MeSH terms

• Type2 Diabetes

Intervention

Other:
• Low Carbohydrate Diet
Dietary choices are counseled to come primarily from lean meats, eggs, nuts, seeds, vegetables and berries.
• Time Restricted Feeding
Participants will be asked to have 2 meals within an 8 hour period, preferably before 2pm.

Locations

Country	Name	City	State
United States	University of Wisconsin Hospital and Clinics	Madison	Wisconsin
United States	UW Health Union Corners Clinic	Madison	Wisconsin
United States	UW Health West Clinic	Madison	Wisconsin

Sponsors (1)

Lead Sponsor	Collaborator
University of Wisconsin, Madison

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Effectiveness of Intervention: Changes in Hemoglobin A1c	Changes in A1c will be measured at baseline, 3 and 6 month MD visits. Data will be extracted from HealthLink by chart review. Comparisons will be made between post-intervention A1c scores and baseline scores, at 1 month and at 3 months using paired t-tests to detect whether patients experienced a positive outcome.	baseline, 3 months, 6 months
Primary	Effectiveness of Intervention: Changes in Insulin Dosage	Changes in insulin dosage will be measured at baseline, 3 and 6 month MD visits. Data will be extracted from HealthLink by chart review.	baseline, 3 months, 6 months
Secondary	Participant Satisfaction	Participant satisfaction with the protocol will be assessed at 3 and 6 months. This will include questions about difficulty, barriers to implementation, and impact on family. Quantitative and qualitative analysis will be performed to determine barriers and facilitators to maintaining TRF and low carbohydrate diet. Semi-structured phone interviews will be performed with 10 of the patients (5 who maintained the LC/TRF protocol and 5 who did not) to understand the impact of the TRF and low carbohydrate diet on their daily lives and determine barriers and facilitators. Interviews will be transcribed and thematic analysis will be performed.	3 months, 6 months
Secondary	Change in Appraisal of Diabetes Scale (ADS) Score	Participant quality of life (QoL) will be assessed at baseline, 3 and 6 months with the Appraisal of Diabetes Scale (ADS). The ADS is a validated tool to measure patients' appraisal of how well they can care for their diabetes and its impact on their life. It is a 7-item survey with each question scored on a likert scale (1-5) for a total range of possible scores 7-35, where lower scores indicate better QoL. Statistical analysis will be performed using paired t-tests or non-parametric methods based on distribution to evaluate ADS changes over time.	baseline, 3 months, 6 months
Secondary	Clinic-level feasibility: Average Hours of Support Time per Participant	MD and RD clinic time along with RN phone support will be logged with each encounter to provide a quantitative assessment of the resources required to implement this type of intervention on a clinic scale. Descriptive statistics with means and standard deviations per patient will be calculated for each class of health care provider.	up to 6 months
Secondary	Effectiveness of Intervention: Changes in BMI	Changes in BMI will be measured at baseline, 3 and 6 month MD visits. Data will be extracted from HealthLink by chart review. Weight and height will be combined to report BMI in kg/m^2.	baseline, 3 months, 6 months
Secondary	Feasibility: Percent of days where food was eaten within the target timeframe	Participant compliance with time-restricted feeding will be evaluated using monthly journals logging first and last food intake each day. The journals will be mailed to Dr. Zimmermann via pre-addressed/stamped security envelopes or brought to appointments. Time-restricted feeding compliance will be calculated using descriptive statistics to determine the % of days where all food was eaten within the target timeframe. Analysis will be done for all data available, data from participants with logs for >50% of days, and participants with logs for >75% of days.	up to 6 months
Secondary	Feasibility: Average Daily Calories	Participant compliance with recommended carbohydrate intake will be evaluated based on data from the registered dietitian (RD) dietary review. RD will calculate daily grams of carbohydrate and total calories. Compliance will be calculated with descriptive statistics for % of days compliant with <30g, 30-60g, >60g of carbohydrates as well as average daily calories.	up to 6 months
Secondary	Feasibility: Percent of day compliant with Carbohydrate target	Participant compliance with recommended carbohydrate intake will be evaluated based on data from the registered dietitian (RD) dietary review. RD will calculate daily grams of carbohydrate and total calories. Compliance will be calculated with descriptive statistics for % of days compliant with <30g, 30-60g, >60g of carbohydrates as well as average daily calories.	up to 6 months